195 related articles for article (PubMed ID: 31645218)
1. Seroprevalence of herpes simplex virus types 1 and 2 in Nigeria: a systematic review and meta-analyses.
Reward EE; Muo SO; Orabueze INA; Ike AC
Pathog Glob Health; 2019 Jul; 113(5):229-237. PubMed ID: 31645218
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.
Bradley H; Markowitz LE; Gibson T; McQuillan GM
J Infect Dis; 2014 Feb; 209(3):325-33. PubMed ID: 24136792
[TBL] [Abstract][Full Text] [Related]
3. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.
Xu F; Sternberg MR; Kottiri BJ; McQuillan GM; Lee FK; Nahmias AJ; Berman SM; Markowitz LE
JAMA; 2006 Aug; 296(8):964-73. PubMed ID: 16926356
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997-1998.
Hellenbrand W; Thierfelder W; Müller-Pebody B; Hamouda O; Breuer T
Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):131-5. PubMed ID: 15692814
[TBL] [Abstract][Full Text] [Related]
5. The Epidemiology of Herpes Simplex Virus Type 1 in Asia: Systematic Review, Meta-analyses, and Meta-regressions.
Khadr L; Harfouche M; Omori R; Schwarzer G; Chemaitelly H; Abu-Raddad LJ
Clin Infect Dis; 2019 Feb; 68(5):757-772. PubMed ID: 30020453
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus infection in the Croatian population.
Vilibic-Cavlek T; Kolaric B; Ljubin-Sternak S; Mlinaric-Galinovic G
Scand J Infect Dis; 2011 Dec; 43(11-12):918-22. PubMed ID: 21696254
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan.
Doi Y; Ninomiya T; Hata J; Yonemoto K; Tanizaki Y; Arima H; Liu Y; Rahman M; Iida M; Kiyohara Y
J Epidemiol; 2009; 19(2):56-62. PubMed ID: 19265271
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study.
Onu EN; Ekuma UO; Judi HK; Ogbu O; Okoro N; Ajugwo GC; Akrami S; Okoli CS; Anyanwu CN; Saki M; Edeh PA
BMJ Open; 2023 Apr; 13(4):e069339. PubMed ID: 37072358
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany.
Rabenau HF; Buxbaum S; Preiser W; Weber B; Doerr HW
Med Microbiol Immunol; 2002 Mar; 190(4):153-60. PubMed ID: 12005327
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes.
Wutzler P; Doerr HW; Färber I; Eichhorn U; Helbig B; Sauerbrei A; Brandstädt A; Rabenau HF
J Med Virol; 2000 Jun; 61(2):201-7. PubMed ID: 10797375
[TBL] [Abstract][Full Text] [Related]
11. Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States.
Chemaitelly H; Nagelkerke N; Omori R; Abu-Raddad LJ
PLoS One; 2019; 14(6):e0214151. PubMed ID: 31170140
[TBL] [Abstract][Full Text] [Related]
12. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic.
Austin H; Macaluso M; Nahmias A; Lee FK; Kelaghan J; Fleenor M; Hook EW
Sex Transm Dis; 1999 Jul; 26(6):329-34. PubMed ID: 10417020
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus infections among rural residents in eastern China.
Lin H; He N; Su M; Feng J; Chen L; Gao M
BMC Infect Dis; 2011 Mar; 11():69. PubMed ID: 21414231
[TBL] [Abstract][Full Text] [Related]
14. [Serological response to herpes simplex virus type 1 and 2 infection among women of reproductive age].
Dordević H
Med Pregl; 2006; 59(11-12):591-7. PubMed ID: 17633904
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.
Woestenberg PJ; Tjhie JH; de Melker HE; van der Klis FR; van Bergen JE; van der Sande MA; van Benthem BH
BMC Infect Dis; 2016 Aug; 16():364. PubMed ID: 27484304
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of herpes simplex virus type 2 in the Middle East and North Africa: Systematic review, meta-analyses, and meta-regressions.
Harfouche M; Alareeki A; Osman AMM; Alaama AS; Hermez JG; Abu-Raddad LJ
J Med Virol; 2023 Mar; 95(3):e28603. PubMed ID: 36815489
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014.
Marchi S; Trombetta CM; Gasparini R; Temperton N; Montomoli E
J Prev Med Hyg; 2017 Mar; 58(1):E27-E33. PubMed ID: 28515628
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of HSV-1 and HSV-2 in Barbados.
Levett PN
Med Microbiol Immunol; 2005 Jan; 194(1-2):105-7. PubMed ID: 15156399
[TBL] [Abstract][Full Text] [Related]
20. National estimates of seroincidence and seroprevalence for herpes simplex virus type 1 and type 2 among US military adults aged 18 to 29 years.
Page WF; Chubb M; Feng X; Fan LY; Li Y; Weber NS; Levin LI; Niebuhr DW
Sex Transm Dis; 2012 Apr; 39(4):241-50. PubMed ID: 22421688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
